Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | 0.19 | N/A | N/A | N/A |
2024-08-08 | 2024-06 | 0.14 | 0.54 | 0.4 | 285.71% |
2024-04-29 | 2024-03 | 0.34 | 0.62 | 0.28 | 82.35% |
2024-02-28 | 2023-12 | -0.05 | 0.04 | 0.09 | 180.00% |
2023-11-02 | 2023-09 | 0.08 | 0.3 | 0.22 | 275.00% |
2023-08-07 | 2023-06 | -0.01 | 0.1 | 0.11 | 1100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-19 | Goldman Sachs | Upgrade | Sell | Sell |
2023-10-08 | Barclays | Upgrade | Underweight | Underweight |
2023-10-08 | Needham | Upgrade | Buy | Buy |
2023-10-05 | Bernstein | Upgrade | Underperform | |
2023-10-05 | Seaport Global | Upgrade | Buy | |
2023-10-01 | Guggenheim | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-05-07 | BYRNE BARBARA M | Director | 43.35K | Stock Award(Grant) |
2024-08-22 | CHOPRA NAVEEN KUMAR | Chief Financial Officer | 194.78K | Conversion of Exercise of derivative security |
2024-05-07 | GRIEGO LINDA M | Director | 64.51K | Stock Award(Grant) |
2024-05-07 | KLIEGER ROBERT N | Director | 38.19K | Stock Award(Grant) |
2024-05-07 | MCHALE JUDITH A | Director | 42.26K | Stock Award(Grant) |
2024-06-30 | PHILLIPS CHARLES E JR. | Director | 101.28K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Berkshire Hathaway, Inc | 93.73M | 1.49B | 15.36% |
2023-06-29 | Vanguard Group Inc | 58.85M | 936.30M | 9.64% |
2023-06-29 | Blackrock Inc. | 40.38M | 642.52M | 6.62% |
2023-06-29 | State Street Corporation | 30.38M | 483.30M | 4.98% |
2023-06-29 | Morgan Stanley | 13.87M | 220.75M | 2.27% |
2023-06-29 | Invesco Ltd. | 13.56M | 215.74M | 2.22% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 15.53M | 247.11M | 2.54% |
2023-06-29 | Vanguard 500 Index Fund | 12.07M | 192.07M | 1.98% |
2023-06-29 | Vanguard Mid-Cap Index Fund | 11.32M | 180.09M | 1.85% |
2023-06-29 | Growth Fund Of America Inc | 10.61M | 168.84M | 1.74% |
2023-08-30 | SPDR (R) Idx Shares-SPDR Communication Services Select Sector ETF | 7.48M | 112.88M | 1.23% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 7.47M | 113.56M | 1.22% |
Dividend | Date |
---|---|
0.05 | 2024-09-16 |
0.05 | 2024-06-17 |
0.05 | 2024-03-14 |
0.05 | 2023-12-14 |
0.05 | 2023-09-14 |
0.05 | 2023-06-14 |
-
-
-
-
$PARA anyone selling here is for peanuts. There is a real case this hits $90 this week.
-
$PARA rumour is Apple buyout $92 a share.. heard it hear first. Youβre welcome
-
$PARA this is going to rocket. IT IS squeezing donβt be fooled
-
$PARA This is going to see $40 minimum tmrw. Big players take a moment to step in and shorts are praying trying to get out
-
Omg no one sell. Anyone who actually understands finance understands this can be $50 by tmrw morning. It is crazy but quite actually possible
-
$PARA rumour Netflix is interested in 40 bill buyout.. so much short interest. Plus the earnings is 3x expected. This is going to rocket tomorrow
-
$PARA this is squeezing hard. Good chance we can see 25 tomorrow.
-
$PTC Therapeutics(PTCT.US)$ Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date. -
-
-
-
-
-
-
-
-
GE HealthCare announces cash dividend for third quarter of 2024
news.google.com • -
TriNet Announces Quarterly Dividend
news.google.com • -
Scholastic Corporation Announces Second Quarter Dividend
news.google.com • -
Paramount (NASDAQ:PARA) Death Spiral? Ad Group Takes Layoffs
news.google.com • -
Stock Market Today: Stock Market News And Analysis
news.google.com • -
AI Stocks: Tech Giants Face New 'Show Me' Moment
news.google.com • -
Cibus Announces Pricing of Public Offering of Class A Common Stock
news.google.com • -
Top 10 Stock Market Investment Strategies for Long-Term Growth
news.google.com • -
More Sports on Paramount (NASDAQ:PARA) With Expanded Masters Coverage
news.google.com • -
Objective long/short (PARA) Report
news.google.com • -
Earnings Calendar, Analyst Estimates And Earnings Reports To Watch
news.google.com • -
NextPlat Announces Results of Annual Meeting of Stockholders
news.google.com • -
RE/MAX NATIONAL HOUSING REPORT FOR AUGUST 2024
news.google.com • -
ECD Regains Compliance with Nasdaq Continued Listing Requirement
news.google.com • -
LXP Industrial Trust Announces Quarterly Common Share Dividend
news.google.com • -
Why Paramount Global-B (PARA) is a Top Value Stock for the Long-Term
news.google.com • -
Why Paramount Global-B (PARA) is a Top Value Stock for the Long-Term
news.google.com • -
10 Best Value Stocks to Buy Now | Investing
news.google.com • -
Best Brokers for Beginners -- Used and Reviewed by Our Experts
news.google.com • -
8 Best Free Stock Trading Apps for September 2024
news.google.com • -
Larry Ellison to control Paramount Global after Skydance merger, filings show
proactiveinvestors.com • -
Paramount Set for Skydance Takeover After Bronfman Withdraws Bid
investopedia.com • -
Bronfman exits Paramount bidding war, leaving Skydance with clear takeover path
proactiveinvestors.co.uk • -
Edgar Bronfman drops Paramount bid
businessinsider.com •